No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Benchmark Co. Initiates XOMA Corp(XOMA.US) With Buy Rating, Announces Target Price $35
Express News | XOMA Royalty Corp : Benchmark Initiates Coverage With Buy Rating; Target Price $35
XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability
Express News | XOMA Royalty Completes Sale of Kinnate Pipeline Assets
BioInvent Earns $1 Million Payment From Mezagitamab Drug Licensing Deal
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference